EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences ...
The Federal Communications Commission (“FCC” or “Commission”), under the leadership Chairman Brendan Carr, has been engaged ...
An expert discusses how maintenance lurbinectedin plus atezolizumab should be followed by standard second-line tarlatamab therapy at progression, as the maintenance approach doesn't change subsequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback